Académique Documents
Professionnel Documents
Culture Documents
BRONCHIAL ASTHMA
Airway inflammation Episodic, reversible bronchospasm Chronic inflammation that leads to marked bronchial hyperreactivity
BRONCHIAL ASTHMA
BRONCHIAL ASTHMA
AC Dilatation
CAMP
ATP
AMP
Bronchial Tone
Acetylcholine Leukotrienes
PDE
Adenosine
Constriction
BRONCHIAL ASTHMA
Release of several mediators from IgEsensitized mast cells and other cells involved in immunologic responses Mediators include
Leukotrienes Chemoattractants Cytokines Enzymes
bronchodilators
the airways
Corticosteroids Cromolyn
Relaxation
CAMP
ATP AMP
Bronchial Tone
Acetylcholine Leukotrienes
PDE
Adenosine
Constriction
responsiveness) is an unwanted effect COPD patients often with concurrent cardiac disease may have arrhythmias at normal dosage
that degrades cAMP to AMP, thus increases cAMP Anti-PDE effect requires high concentration of the drug
Relaxation
ATP CAMP AMP
Bronchial Tone
Acetylcholine Leukotrienes
PDE
Adenosine
Constriction
Slow-release theophylline
For control of nocturnal asthma
claudication
Relaxation
CAMP
ATP AMP
Bronchial Tone
Acetylcholine Leukotrienes
PDE
Adenosine
Constriction
(especially children) No effect on the inflammatory aspects of asthma Useful in many COPD patients
Tiotropium
Newer longer-acting analog
absorbed Systemic effects are small In excessive dosage, minor atropine-like toxic effects may occur Does not cause tremor or arrhythmias
(leukotrienes and histamine) from mast cells Prevents both early and late responses to challenge
Asthma in children
Most important use
Hay fever
Nasal and eyedrop formulations
AGONISTS
MUSCARINIC ANTAGONISTS
phospholipase A2 Inhibit the expression of COX-2 (antianflammatory action) Postulated that: this drugs increases the responsiveness of beta agonists in the airway
Lipid
Arachidonic acid
Lipooxygenase
Cyclooxygenase
Hydroxypeptidase
Endoperoxidase
Leukotrienes
Prostacycline
Prostaglandin
Thromboxane A2
Flunisolide
Fluticasone Mometasone
severe asthma Appropriate (even in children) in cases of moderate asthma that does not fully respond to aerosol agonist
Adrenal suppression can be reduced by using alternate day therapy (give the drug in slightly higher dosage every other day)
Occur if treatment is required for more than 2 weeks Regular use of inhaled steroids cause mild growth retardation in children
LEUKOTRIENE
ANTAGONISTS
AGONISTS
MUSCARINIC ANTAGONISTS
RELEASE INHIBITORS
STEROIDS
Lipooxygenase
Cyclooxygenase
Hydroxypeptidase
Endoperoxidase
Leukotrienes
Prostacycline
Prostaglandin
Thromboxane A2
Exercise- and antigen-induced bronchospasm Aspirin allergy Toxicity include occasional elevation of liver enzymes
Humanized murine monoclonal antibody to human IgE Prophylactic management of asthma Given parenterally
mediators